Patent · US Active

Methyl-benzimidazole derivatives

US8008503B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Gregory Martin Benson · Therwil, CH
Konrad Bleicher · Glückstadt, DE
Uwe Grether · Weil am Rhein, DE
Rainer E. Martin · Basel, CH
Jean-Marc Plancher · Rixheim, FR
Hans Richter · Weil am Rhein, DE
Sven Taylor · Riedisheim, FR
Minmin Yang · Nanjing, CN

Key dates

Filing date	Aug 25, 2010
Grant date	Aug 30, 2011
Priority date	—
Expiry date	Aug 25, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is concerned with novel substituted benzimidazole derivatives of formula (I)wherein R1 to R10 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds can be used as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.